Regeneron Pharmaceuticals
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Regeneron Pharmaceuticals (REGN) SEC Filings
Browse all Regeneron Pharmaceuticals SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more
Regeneron Pharmaceuticals Reports: Annual 10-K, Quarterly 10-Q & SEC Filings
SEC Filings
Date
2026
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
13F-HR
Quarterly equity holdings of institutional investment managers
10-K
Annual financial results and management updates
8-K
Material company events (earnings, M&A, or leadership changes)
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
2025
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
13F-HR
Quarterly equity holdings of institutional investment managers
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
Regeneron Pharmaceuticals (Form 4) 2026
Insider Trades / Insider ownership (buying, selling) activity
Mar 3, 2026
